e-learning
resources
Berlin 2008
Wednesday, 08.10.2008
Airway cell biology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Soluble forms of differentiated antigens in COPD
N. Kubysheva, L. Postnikova, V. Novikov (Nizhny Novgorod, Russian Federation)
Source:
Annual Congress 2008 - Airway cell biology
Session:
Airway cell biology
Session type:
E-Communication Session
Number:
4486
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Kubysheva, L. Postnikova, V. Novikov (Nizhny Novgorod, Russian Federation). Soluble forms of differentiated antigens in COPD. Eur Respir J 2008; 32: Suppl. 52, 4486
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Decrease of soluble adhesion molecules levels and bacterial mixt-infection in patients with COPD
Source: Annual Congress 2011 - COPD: human studies
Year: 2011
Circulating mature and progenitor eosinophils in patients with stable asthma express all major traffic related receptors
Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms
Year: 2012
The content of soluble forms of activated molecules of leukocytes in the blood serum of patients with chronic bronchitis
Source: Eur Respir J 2004; 24: Suppl. 48, 36s
Year: 2004
Triggering receptor expressed on myeloid cells (TREM)-1 and its soluble form (sTREM-1) as a diagnostic marker of bacterial lung infection
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008
Alterations of the soluble proteome of airway epithelial cells in COPD
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013
Soluble forms of CD95 (fas/apo-1), cd38 and CD25 antigens in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Pleural and parenchymal diseases
Year: 2009
Anti-rhinoviral activity of soluble ICAM-1/FC fusion protein in primary airway epithelial cells from COPD patients
Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection
Year: 2009
Expression of selected surface markers on macrophages in induced sputum from patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 436s
Year: 2003
Expression of surface receptors on alveolar macrophages and monocytes from patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 453s
Year: 2004
Reduced expression of CD44 on lung macrophages from patients with COPD
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
Phenotyping neutrophils in COPD through surface proteins
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019
Characterization of well-differentiated bronchial epithelial cells derived from severe COPD patients
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021
Soluble ICAM-1 and ICAM-3 antigens in chronic obstructive pulmonary of lungs
Source: Annual Congress 2009 - Inflammatory cells and cytokines
Year: 2009
Upregulation of the high-affinity IgE receptor on plasmacytoid dendritic cells in severe COPD
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Antigen presenting cells of lower airways in interstitial lung diseases (ILD). Do alveolar lymphocytes possess the ability to present antigens?
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010
Phenotype of dendritic cells (DCs) stimulated by microbial antigens in COPD patients with frequent and infrequent exacerbations.
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017
Distinct localization of estrogen receptors in lungs of severe COPD patients
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Circulating adhesion molecules as prognostic markers in childhood asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 160s
Year: 2004
Serum levels of soluble forms of intracellular adhesion molecules in patients with community acquired pneumonia
Source: Annual Congress 2008 - Airway infection and host defence
Year: 2008
Role of low-grade inflammation markers and soluble cell adhesion molecules in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept